Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134533) titled 'Research on the Establishment of a Multi-Omics-Based Precision Diagnostic System for Urothelial Carcinoma and Recurrence Monitoring Technology' on Oct. 16.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University
Condition:
This study involves diseases of urothelial carcinoma (including bladder urothelial carcinoma and upper urinary tract urothelial carcinoma of the renal pelvis/ureter). Common clinical presentations include painless gross hematuria or microscopic hematuria, with or without lower urinary tract irritati...